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ABSTRACT The effects of binding of myristoylated ADP ribosylation factor 6 (myr-ARF6), an activator of phospholipase D
(PLD), to a model membrane were investigated using an electron spin resonance (ESR) labeling technique. Initial studies were
conducted in vesicles composed of 1-palmitoyl-2-oleoyl phosphatidylethanolamine, dipalmitoylphosphatidylcholine, phos-
phatidylinositol 4,5-biphosphate (PIP2), and cholesterol. Recombinant ARF6 binding significantly enhances defects in both
the headgroup and acyl-chain regions of the membrane, which are revealed by the emergence of sharp components in the
spectra from a headgroup label, 1,2-dipalmitoylphosphatidyl-2,2,6,6-tetramethyl-1-piperidinyloxy-choline (DPPTC), and a
chain label, 10PC, after myr-ARF6 binding. Binding of non-myristoylated ARF6 (non-ARF6) shows markedly reduced effects.
Interestingly, no change in spectra from DPPTC was observed upon myr-ARF6 binding when PIP2 in the vesicles was
replaced by other negatively charged lipids, including phosphatidylinositol, phosphatidylserine, and phosphatidylglycerol,
even when normalized for charge. The production of the sharp peak appears to be a specific event, because another GTP
binding protein, CDC42, which binds PIP2 and activates PLD, fails to induce changes in vesicle structure. These results
suggest a previously unappreciated role for ARF in mediating a protein/lipid interaction that produces defects in lipid bilayers.
This function may serve as an initial event in destabilizing membrane structure for subsequent membrane fusion or biogenesis
of vesicles.
INTRODUCTION
Elucidation of the mechanism of cell vesicular transport
processes is still a challenge to both biochemists and bio-
physicists. Previous studies focused on protein-protein in-
teractions and internal transport pathways (reviewed in
Rothman, 1994; Sudhof, 1995). However, at present the
molecular processes that lead to disruption of membrane
structure, which are required in vesicle budding and vesicle-
membrane fusion, are not well understood.
Recent work by a number of investigators has suggested
a role for PLD and its activators in membrane transport and
remodeling processes (reviewed by Roth and Sternweis,
1997; Jones et al., 1999). Activation of PLD and the sub-
sequent formation of phosphatidic acid have been suggested
to facilitate the association of coat proteins to Golgi mem-
branes and thereby to participate in processes of vesicle
transport (Ktistakis et al., 1996). New evidence suggests
that bioactive lipids by phospholipases may play a central
role in membrane changes that are critical to regulated
exocytosis (Chen et al., 1997; Freyberg et al., 2001; Cohen
and Brown, 2001, Ivanova et al., 2001). Stimulation of PLD
may be initiated through an interaction with an ARF GT-
Pase protein (Brown et al., 1993; Cockcroft et al., 1994). An
acidic phospholipid, PIP2, also appears to function as an
essential co-factor in the activation of PLD1 (Brown et al.,
1993). These findings implicate the possible participation of
PLD and ARF in protein-lipid interactions that play central
roles in the modification of membrane structure. At
present the molecular basis of such interactions are poorly
defined.
To initiate our study we focused on interactions of ARF
with membranes. A headgroup label and three chain-labeled
PCs were incorporated into a model membrane to monitor
effects of these interactions. ESR spectra from the model
membrane upon binding of ARF6 were compared with
those upon binding of other proteins, e.g., CDC42, cyto-
chrome C, and synthetic peptides of residues 1–17 of myr-
istoylated and non-myristoyled human ARF6 (r17-myr-
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ARF6 and r17-non-ARF6). To test the requirement of
myristoylation for ARF binding and effective interactions
with lipid bilayers, both myr-ARF6 and non-ARF6 were
prepared in the presence of GDP. Interactions between ARF
and PIP2 have been reported, yet controversies have per-
sisted (Antonny et al., 1997; Terui et al., 1994), so investi-
gations were performed on myr-ARF6 binding to the mem-
brane containing PIP2 and to membranes in which PIP2 was
replaced by other negatively charged lipids, such as PI, PG,
and PS. It is shown by spectral subtractions and NLLS fits
that the main change in ESR spectra from the model mem-
brane containing PIP2 upon myr-ARF6 binding is the emer-
gence or enhancement of sharp spectral components, which
are superimposed on the main components.
The aim of this study is to correlate the sharp components
in ESR spectra from spin-labeled membrane systems with
defects in lipid bilayers. We provide evidence for defects in
DPPC bilayers, associate them with sharp components in
ESR spectra from DPPC membranes and then show that
these sharp components can be significantly enhanced or
reduced through lipid/lipid or lipid/protein interactions. By
simple analogy, we suggest that the sharp components in the
ESR spectra from the model membrane containing PIP2
upon myr-ARF6 binding arise from defects in the bilayers
induced or enhanced by specific interactions between myr-
ARF6 and PIP2. The significance of defects induced by
lipid-lipid and lipid-protein interactions in membrane vesic-
ulation and membrane fusion processes, as well as the
ability of ARF to modulate availability of substrate to PLD,
are discussed.
MATERIALS AND METHODS
Expression and purification of recombinant
ARF6 proteins
We expressed human ARF6 based on procedures developed by Hong et al.
(1994) and Lodge et al. (1997). Cultures (4 ml) of transformed Escherichia
coli were started directly from 15% glycerol stocks and grown for 13 h at
37°C in an air shaker at 200 RPM. For preparation of myr-ARF6, main-
tenance of both the ARF6 and N-myristoyl transferase plasmids was
accomplished through dual antibiotic selection using 300 g/ml carbeni-
cillin and 112 g/ml kanamycin. Preparation of non-ARF6 was conducted
under carbenicillin selection at 300 g/ml to maintain the ARF6 plasmid.
These plasmids were generous gifts of Dr. Joel Moss at the National
Institutes of Health. Cultures were spun to pellet bacteria, and pellets were
washed twice in LB media. Pellets were resuspended in 4 ml of minimal
medium (17 mM NaCl, 37 mM NH4Cl, 95 mM Na2HPO4, 17 mM
K2HPO4, 2 mM MgSO4, 0.1 mM CaCl2, 0.4% glucose), and 1 ml was
inoculated into 200 ml of minimal medium at identical antibiotic condi-
tions. Cultures were grown at 37°C until OD600 was between 0.6 and 0.9.
The cultures (200 ml) were added directly to 4 L of minimal medium in a
fermenter flask and grown at 37°C at 200 RPM and 20 L/min air flow.
Myristic acid (200 mg dissolved in 100% ethanol and diluted to 3.3%
ethanol in sterile water) was added 1:133 to the fermenter at an OD600 of
0.6. At OD600 1.0, cells were induced at 0.3 mM isopropyl b-D-thioga-
lactopyranoside. Cultures were supplemented with 40 ml of 20% glucose
and 930 mg of carbenicillin and 225 mg of kanamycin. Three hours after
incubation, 400 ml of 1 M sterile sodium phosphate was added to cultures
to maintain a neutral pH. Total induction time was 9 h. After induction,
cells were pelleted by centrifugation, washed, and frozen at 80°C.
The purification of ARF6 was accomplished using an adaptation of
previous chromatographic methods (Randazzo et al., 1995; Brown and
Sternweis, 1995). Cells were resuspended in lysis buffer (20 mM Tris, pH
8.0, 1 mMMgCl2, 1 mM dithiothreitol, 100 mM NaCl, 100 MGDP), plus
protease inhibitors (130 M phenylmethylsulfonyl fluoride, 1 g/ml pep-
statin A, 1 g/ml leupeptin, 1 g/ml aprotinin, 10 g/ml trypsin inhibitor,
20 g/ml Na-P-tosyl-L-lysine chloromethyl ketone, 20 g/ml N-tosyl-L-
phenylalanine chloromethyl ketone). Lysozyme (4 mg) was added, and the
cell suspension was frozen for 30 min at80°C. The cell suspension was
thawed, 1 mg/ml of DNAse was added, and samples were sonicated using
a Sonic Dismembrator 550 (Fisher Scientific, Springfield NJ) probe soni-
cator (eight cycles alternating between on and off in 1-s intervals). Lysed
cells were spun at 100,000  g for 1 h. Supernatant was removed and
diluted 1:4 in buffer (without NaCl) to reduce the NaCl concentration to a
final concentration of 25 mM. The pellet was resuspended in lysis buffer
(with 25 mM NaCl and 0.1% -octyl-glucoside). The resuspended pellet
was spun at 100,000  g for 1 h. Supernatant was removed and combined
with the first supernatant. ARF6 mixture was added to a 90-ml diethyl-
aminoethyl-Sephacel column equilibrated with lysis buffer containing 25
mM NaCl. The flow-through and two column washes were collected
(containing the ARF6). The flow-through and washes were concentrated to
1.5 ml using an Amicon concentrator with PM10 membrane. Concentrated
ARF6 was applied to a 160-ml bed volume AcA44 gel filtration column,
and proteins were chromatographically resolved in lysis buffer containing
25 mM NaCl. Fractions 72–84 containing the ARF6 were pooled and
concentrated, typically to 2–5 mg/ml. The modified and unmodified pro-
teins were compared by sodium dodecyl sulfate polyacrylamide gel elec-
trophoresis using a gel shift assay (Franco et al., 1995). The ARF6 proteins
were concentrated and stored at 80°C. The purification of the recombi-
nant CDC42 protein expressed in E. coli was accomplished essentially as
described in Walker et al. (2000). The initial 17 amino acids corresponding
to human ARF6 (r17-ARF6) were custom synthesized either with or
without a myristic acid modification (Sigma Genosys).
Preparation of ESR samples
Materials
Lipids POPE, DPPC, liver PI (sodium salt), DOPG (sodium salt), DOPS
(sodium salt), and spin labels DPPTC, 5PC, 10PC, and 16PC (the chemical
structure of 16PC is shown in Fig. 1) were purchased from Avanti (Ala-
baster, AL). Gm1 was purchased form Matreya (Pleasant Gap, PA). They
FIGURE 1 The chemical structures of spin label DPPTC, 4PT, and
16PC.
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were used without further purification. PIP2 (sodium salt) is a product of
Roche Diagnostics Co. (Indianapolis, IN). Spin label 4PT (chemical struc-
ture shown in Fig. 1) was purchased from Aldrich (Milwaukee, WI) (at pH
7, 4PT is a water-soluble spin label but insoluble in the hydrophobic
interior of bilayers). CHOL, CTB, and cytochrome C are products of Sigma
Chemical Co. (St. Louis, MO).
Preparation of dispersions and binding of proteins
The dispersion used in this study is composed of POPE, DPPC, CHOL, and
PIP2 at molar ratios of 114:11:1.6:6. Because this dispersion has been used
for measuring PLD activity in an exogenous assay (detailed in Brown and
Sternweis, 1995), in which the amount of PC hydrolyzed by PLD can be
quantitatively controlled and measured, it was chosen as a model mem-
brane for this study. In the following, unless otherwise specified, the
dispersion refers to the model membrane with the above composition. Its
preparation procedure is described as follows. Measured stock solutions of
lipid (in chloroform, except for PIP2 in chloroform:methanol 2:1 (v/v)) and
of spin label were mixed thoroughly in a glass tube. The weight of dry
lipids was 0.25 mg, and the concentration of spin label was 0.5 mol % of
the total lipids. As the solvent was evaporated by N2 flow, the dried lipids
formed a thin film on the wall of the tube, and then the sample was
evacuated with a mechanical pump overnight to remove trace amounts of
solvent. After addition of 50 l of pH 7.0 Tris buffer (50 mM Tris, 160 mM
NaCl, and 0.1 mM EDTA), the lipids were scraped off the wall and kept
in the dark at room temperature for 2 h. The vesicle solution was vortexed
for 1 min, and 10 l of the solution was then transferred into a capillary (ID
0.8–1.1 mm) for ESR measurement. For protein binding, after the disper-
sion was hydrated for 2 h, a calculated amount of protein solution was
added, and the dispersion was vortexed for 1 min and applied for ESR
measurements.
Binding of CTB to a model membrane
The procedure to prepare the model membrane for CTB binding is similar
to that described above. The composition of the membrane is DPPC
(DSPC):Gm1:CHOL  9(9):1:10. The concentration of the spin label
10PC is 0.5 mol % of total lipids (0.5 mg in weight). The dried lipid
mixture was hydrated with 0.5 ml of pH 7.0 Tris buffer (50 mM Tris, 10
mM NaCl, and 0.1 mM EDTA) for 2 h. Meanwhile, CTB powder (2 g) was
dissolved in 1 ml of deionized water, the resulting solution contains 1 mg
of CTB, 50 mM Tris, 200 mM NaCl, 3 mM NaN3, and 1 mM EDTA. Then
10 l of the vesicle solution and 10 l of the CTB solution were mixed and
transferred into a capillary (ID 0.8–1.1 mm) for ESR measurement.
Preparation of LUVs of pure DOPC and of DOPC/PIP2 at
molar ratio of 95:5
The procedure for mixing DOPC, PIP2 and the spin label DPPTC (0.5 mol
% of total lipids) is the same as that for preparing the dispersions described
above. The weight of total lipids is 2 mg, and 200 l of pH 7.0 Tris buffer
(50 mM Tris, 160 mM NaCl, and 0.1 mM EDTA) was added to the dried
lipid mixture. The lipids were scraped off the wall, and the vesicle solution
was extruded through a stack of membrane filters with pore sizes of 0.4,
0.2, and 0.1 m (Millipore, Bedford, MA) in an extruder (Lipex Biomem-
branes, Vancouver, British Columbia, Canada) five times.
ESR spectroscopy and NLLS analysis
of ESR spectra
ESR spectra were obtained on a Bruker Instruments (Billerica, MA) EMX
ESR spectrometer at a frequency of 9.34 GHz. All spectra were digitized
to 1024 points and had 120 Gauss sweep widths. All spectra were taken
at 23°C.
NLLS analyses of the spectra based on the stochastic Liouville equation
(Meirovitch et al., 1982; Schneider and Freed, 1989) were performed using
the latest version of the fitting program (Budil et al., 1996). They yield the
following parameters: rotational diffusion rate R and order parameter S.
R is the rotational diffusion rate of the nitroxide radical around an axis
perpendicular to the mean symmetry axis for the rotation. This symmetry
axis is also the direction of preferential orientation of the spin-labeled
molecule (Schneider and Freed, 1989). For 5PC, 10PC, and 16PC, R
represents the rotational wagging motion of the long axis of the acyl chains
(Ge et al., 1994). For the headgroup label DPPTC, it represents the
wagging motion of the ammonium group. For the simulation of ESR
spectra of spin labels incorporated into MLVs, a MOMD model (Meiro-
vitch et al., 1984; Budil et al., 1996) was used. This model is based on the
characteristics of the dynamic structure of lipid dispersions; i.e., locally in
a lipid bilayer fragment, lipid molecules are preferentially oriented by the
structure of the bilayer, but globally, the lipid bilayer fragments are
distributed randomly (Meirovitch et al., 1984). The order parameter S is a
measure of the angular extent of the rotational diffusion of the nitroxide
moiety. The larger the S, the more restricted is the motion, which means
that laterally the lipid molecules are packed more tightly. Therefore, S
reflects the local ordering of lipid molecules in the macroscopically dis-
ordered membrane dispersions. The magnetic A-tensor and g-tensor com-
ponents needed for the simulations were obtained from fits to rigid limit
spectra of the samples, which were taken at liquid nitrogen temperature.
4PT/VC assay
This assay is for measurement of permeability of lipid bilayers. A lipid
dispersion (dry weight 2 mg) is prepared with 0.5 mol % 4PT and hydrated
with 200 l of pH 7 Tris buffer (50 mM Tris, 10 mM NaCl, 0.1 mM
EDTA), as described above, and 4 l of 200 mM VC aqueous solution is
added to the dispersion. Because the amount of VC added is large enough
to kill all the spin label in the dispersion, the supernatant will give no ESR
signal. Whether an ESR signal can be detected from the pellet is deter-
mined by the permeability of the bilayers to VC molecules.
RESULTS
A preliminary ESR experiment
ESR spin labeling has proved to be a powerful technique for
studying lipid-lipid (Ge et al., 1994; Shin and Freed, 1989)
and lipid-protein (Ge and Freed, 1999; Patyal et al., 1997;
Freed, 2000) interactions. To test to what extent the dy-
namic structure of the membrane could be perturbed by
PLD activity, and in particular to test whether the ESR
method is sensitive enough to detect these perturbations, a
preliminary experiment on a model membrane (a disper-
sion) was performed. The dispersion, 0.1 mg in weight, is
composed of PE from liver, DPPC, a headgroup spin label
DPPTC (its chemical structure is shown in Fig. 1), CHOL,
and PIP2 at a molar ratio of 114:5.5:5.5:1.6:6 (86%:8%:1%:
5%). (The dispersion was buffered with 50 mM Na-HEPES
(pH 7.5), 1 mM dithiothreitol, 80 mM KCl, 3 mM EGTA,
3 mM MgCl2, and 2 mM CaCl2 in the presence of GTPs,
a partially purified preparation of ARF from brain, and
protein kinase C of -isoform. The volume of the dispersion
is 1 ml.) Plotted in Fig. 2 are ESR spectra of DPPTC from
two test samples. The upper spectrum was taken from the
996 Ge et al.
Biophysical Journal 81(2) 994–1005
sample that had been incubated in the presence of PLD1
(expressed in Sf21 insect cell cytosol) causing 27% of the
DPPC to be hydrolyzed, whereas the lower one was from
another sample without incubation with PLD1. Both spectra
are composed of two components, a narrower three-line
spectrum superimposed on a very broad spectrum.
Because the sharper component is very similar to those
that will be extensively involved in the ESR spectra we
will present in this paper, we would like to distinguish
between two different sources from which sharp compo-
nents could be generated. 1) For spin labels dissolved in
the bulk aqueous phase (source A), ESR spectra consist
of three narrow hyperfine lines of nearly equal intensity,
which result from fast tumbling motions of these spin
labels (Carrington and McLachlan, 1967). 2) For spin
labels dispersed in the bilayers (source B), ESR spectra
appear narrower, hence sharper, relative to the main very
broad component. This is because the local ordering is
smaller and/or the motion is faster for the former than for
the latter. At physiological temperatures, these relatively
sharper components are nevertheless in the slow motional
regime. In fact, our simulations show that the rotational
diffusion rate and the order parameter for the sharper
components of Fig. 2 are 3.4  108 s1 to 5.2  108 s1
and 0.11–0.18, respectively, which yield slow motional
ESR spectra, (Schneider and Freed, 1989). The line
shapes from source B can thus be easily distinguished
from those of the fast motional spectra from source A,
because they are broader and they show a significant
variation of widths and amplitudes for the three different
hyperfine lines (cf. Fig. 2). In this study we are primarily
interested in the sharper components from the membrane-
bound spin labels (i.e., case 2), because they might be
related to defect formation in the membranes.
A source for A spin labels could be water-soluble
nitroxide radicals, such as those that could result from
breakdown of spin-labeled lipids, or they could be spin
labels that are separated out from the bilayers. However,
in the latter case, the critical micelle concentration of
DPPC is 5  1010 M (Israelachivili, 1991), which is
very low. Introducing a nitroxide radical into DPPC,
either attached to the acyl chain (e.g., 5PC, 10PC, or
16PC) or attached to the headgroup (e.g., DPPTC), might
increase the CMC slightly. But even a factor of 10
increase to 5  109 M in the aqueous phase is still well
below the concentration of spin label, which can be
detected by ESR spectroscopy, 1  107 M4. (The
limit of the number of spins detectable by ESR spectros-
copy as measured in our laboratory is 1 pmol (1  1012
mol). The typical volume of aqueous solution in an ESR
lipid dispersion sample is 10 l, so the limit of concen-
tration of spin label detected by ESR is 1  107 M. This
limit corresponds to an extremely weak, barely detectable
signal, whereas we see substantial signals from the sharp
components.) So it is impossible to observe any ESR
signal from the PC-type spin labels in the aqueous phase
simply because of their low CMC values.
The absence of any ESR spectra from A spin labels
does not rule out the possibility that PLD cleaves not only
DPPC molecules, generating choline, but also DPPTC
spin labels, generating TEMPO-choline, which is an A
spin label. Because TEMPO-choline is water soluble (it
is known that both choline and TEMPO are water solu-
ble; therefore, TEMPO-choline must be also water solu-
ble), once produced it will be quickly reduced by the
reducing agent, NaN3, in the buffer. (The same is, of
course, also true for any DPPTC in the buffered aqueous
phase.) It is, however, difficult for the reducing agent to
access the nitroxide moieties in the DPPTC in the mem-
brane, which is why they can survive substantial periods.
It is seen from Fig. 2 that the relative intensity of the
narrower component is slightly greater in the spectrum from
the sample incubated with PLD1 than that without incuba-
tion with PLD1. This is a small but significant change,
which demonstrates that ESR is sensitive to perturbations in
membrane dynamic structure induced by PLD catalytic
activity.
General features of ESR spectra before and after
myr-ARF6 and non-ARF6 bindings
A headgroup spin label, DPPTC, and three chain spin
labels, 5PC, 10PC, and 16PC, were used to investigate
FIGURE 2 Results from a preliminary experiment. ESR spectra at 20°C
of spin label DPPTC from two dispersion samples with the same compo-
sition: liver PE, DPPC, DPPTC, CHOL, PIP2 of molar ratio 114:5.5:5.5:
1.6:6 (0.86:0.04:0.04:0.01:0.05). The upper spectrum was taken from one
sample that had been incubated in the presence of recombinant PLD1 (Sf21
expressed in cells) with 27% of DPPC being hydrolyzed, whereas the lower
one is from another sample without any incubation with PLD1.
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effects of myr-ARF6 and non-ARF6 on the membrane
dynamic structure when they bind to the membrane sur-
face. The molar ratios of total lipids in the dispersion to
proteins added are 1700 for myr-ARF6 binding and 1000
for non-ARF6 binding. ESR spectra from the four spin
labels in the dispersion before and after myr- and non-
ARF6 binding are shown in Fig. 3. The most notable
changes in ESR spectra are the emergence of a sharper
component in the spectrum from DPPTC and a signifi-
cant increase in intensity of the sharper component in the
spectrum from 10PC upon myr-ARF6 binding. In con-
trast, upon non-ARF6 binding there is only a slight
change in intensity of the low-field peak relative to the
central peak in the spectrum from DPPTC and a small
increase in intensity of the sharper peak in the spectrum
from 10PC. Although no sharp component is seen in
spectra from 5PC and 16PC after ARF6 binding, differ-
ences between the spectra after myr-ARF6 and non-
ARF6 binding can still be discerned. For the spectra from
5PC, the ratio of positive peak intensity l to negative
peak intensity l of the central peak, l/l (see Fig. 3), is
1.45 for the spectrum before ARF6 binding and 1.44 for
the spectrum after non-ARF6 binding, essentially the
same as the former, but it increases significantly to 1.58
for the spectrum after myr-ARF6 binding. For the spectra
from 16PC, the ratio of the peak-peak intensity of the
low-field line to the peak-peak intensity of central line
l1/l0 (see Fig. 3) is the same for the spectra before and
after non-ARF6 binding, 0.81, but it increases signifi-
cantly to 0.87 for the spectrum after myr-ARF6 binding.
In sum, the spectra from 5PC and 16PC remain nearly the
same after non-ARF6 binding but change significantly
after myr-ARF6 binding.
To resolve the sharper component from the broad
component, a simple method is spectral subtraction, i.e.,
subtracting the spectrum before myr-ARF6 binding from
the corresponding spectrum after myr-ARF6 binding.
The difference spectra of DPPTC and 10PC thus obtained
are plotted in Fig. 4, A and B, respectively. For purposes
of comparison, a spectrum from 4PT in DOPC dispersion
in the presence of excess water is shown in Fig. 4 C.
From Fig. 4, we can see the following. 1) The difference
spectrum from 10PC (Fig. 4 B, solid line) has a normal
line shape typical of a slow motional ESR spectrum,
whereas the difference spectrum from DPPTC (Fig. 4 A)
is severely distorted. This indicates that the main broad
component in the spectrum from DPPTC after myr-ARF6
binding may be significantly different from the spectrum
before myr-ARF6 binding. 2) Although the spectrum
from 4PT (Fig. 4 C) is a fast-motion spectrum, the
difference spectra from DPPTC and 10PC are not. It
means that the latter signals are coming from DPPTC and
10PC exclusively dispersed in membranes. The informa-
tion revealed from spectral subtractions is useful but is
limited. To get quantitative information on dynamics and
ordering of the lipid bilayers, NLLS fits to experimental
spectra were conducted.
FIGURE 3 ESR spectra at 20°C from spin labels DPPTC, 5PC, 10PC, and 16PC in a dispersion composed of POPE:DPPC:CHOL:PIP2 of molar ratio
114:11:1.6:6 (0.86:0.08:0.01:0.05) before and after addition of myr-ARF6 and non-ARF6. The molar ratios of myr-ARF/lipids and non-ARF6/lipids are
1700 and 1000, respectively. The experimental spectra are plotted in solid lines, whereas the simulations are in dashed lines. For each simulated spectrum,
two components obtained from NLLS fitting are plotted at the upper right corner except the one from DPPTC before ARF6 binding, which was fit with
only one component. The ratio of positive peak intensity l to negative peak intensity l of the central peak. l/l, measured for the spectra from 5PC,
and the ratio of low-field line peak-peak intensity to central field line peak-peak intensity, l1/l0, measured for the spectra from 10PC are indicated at each
spectrum. The arrows indicate the sharp peaks in the spectra from 10PC.
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A summary of best-fit parameters from
NLLS analyses
NLLS simulations were performed on spectra from DPPTC
and 10PC before and after myr-ARF6 binding. The simu-
lations (dashed lines) are superimposed on the correspond-
ing experimental spectra (solid lines) in Fig. 3. All the
spectra were simulated with two components except the one
from DPPTC before myr-ARF6 binding, which was simu-
lated with only one component. The two components ob-
tained for each fit are plotted as inserts at the upper right
corner of the corresponding experimental spectra in Fig. 3.
The best fit parameters obtained from the simulations are
listed in Table 1. Some features about the ordering and
dynamics of the spin labels revealed from these results are
summarized as follows. 1) The values of S of all sharp
components in spectra from both DPPTC and 10PC, either
before or after ARF6 binding, 0.15–0.23, are much lower
than those of the corresponding broad components, 0.37–
0.40 (10PC) or 0.65 (DPPTC). Thus, sharp components
always have much lower ordering than broad components.
We ascribe the sharp components to spectra generated from
spin labels located in defects of bilayers, as will be dis-
cussed below. 2) The population of the sharp component in
spectra from 10PC increases slightly from 0.11 before
ARF6 binding to 0.13 after non-ARF6 binding and in-
creases significantly to 0.18 after myr-ARF6 binding. This
indicates that myr-ARF6 has a stronger interaction with the
membrane than non-ARF6 does. 3) The difference in R for
spectra from 10PC before and after ARF6 binding is small.
For broad components, the values of R are 1.34  108 s1
before ARF6 binding vs. 1.20  108 s1 after non-ARF6
binding and 1.24  108 s1 after myr-ARF6 binding. They
are in essence the same. For sharp components, it increases
slightly from 1.69  108 s1 before ARF6 binding to
2.34 108 s1 after non-ARF6 binding and 2.18 108 s1
after myr-ARF6 binding. For DPPTC, there is little change
in R for the broad component (6.26  107 s1 before and
5.87  107 s1 after ARF6 binding), whereas the sharp
component that emerges after myr-ARF6 binding exhibits
an increase to 2.00  108 s1. In summary, the effect of
ARF6 binding on the membrane dynamics is relatively
small, but the sharp component for DPPTC displays a
significantly faster rate (by a factor of 3) than the broad
component.
Just as we expected, the S value of the broad component
in the spectrum from DPPTC after myr-ARF6 binding,
0.65, is much larger than that of the spectrum from DPPTC
before myr-ARF6 binding, 0.40. That explains why the
difference spectrum for DPPTC (Fig. 4 A) is distorted. The
reason the difference spectrum for 10PC looks normal also
becomes clear. 1) Both the motional and ordering parame-
ters for the broad and narrow components before and after
myr-ARF6 binding are nearly the same. 2) The major dif-
ference between the spectra before and after myr-ARF6
binding is an increase in relative population of the narrow
component versus the broad components. We superimpose
the sharp component for the spectrum from 10PC after
myr-ARF6 binding obtained from NLLS fitting (dashed
line) on the difference spectrum of 10PC (solid line) (cf.
Fig. 4 B). It is seen that the two spectra are very similar. It
turns out that results from the detailed NLLS fitting and
from the simple spectral subtraction are consistent, in this
case, as they should be.
FIGURE 4 (A) The difference spectrum of DPPTC in the dispersion
obtained by subtracting the spectrum before myr-ARF6 binding from the
spectrum after myr-ARF6 binding; (B) The difference spectrum of 10PC in
the dispersion obtained by subtracting the spectrum before myr-ARF6
binding from the spectrum after myr-ARF6 binding (——) and the sharp
component of the simulation for the spectrum of 10PC after m-ARF6
binding obtained from NLLS fit (— ——); (C) The spectrum from 4PT in
the DOPC dispersion in the presence of excess water.
TABLE 1 Best-fit parameters of R and S from NLLS fits for
ESR spectra of DPPTC and 10PC in the dispersion before and
after myr-ARF6 and non-ARF6 binding
Sample Component R (s1) S Population
DPPTC
Before binding 6.26  107 0.40
After myr-ARF6 binding 1 5.87  107 0.65 0.87
2 2.00  108 0.23 0.13
10PC
Before binding 1 1.34  108 0.39 0.89
2 1.69  108 0.18 0.11
After non-ARF6 binding 1 1.20  108 0.40 0.87
2 2.34  108 0.15 0.13
After myr-ARF6 binding 1 1.24  108 0.37 0.82
2 2.18  108 0.16 0.18
The least-squares estimated error in R is 5% and in S is 0.01.
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Myr-ARF6 binding to dispersions in which PIP2 is
replaced by PI, PG, or PS
ESR spectra from DPPTC in dispersions containing differ-
ent negatively charged lipids, PIP2, PI, DOPG, and DOPS,
before and after myr-ARF6 binding are compared in Fig. 5.
The composition of the dispersions except for the one
containing PIP2 is POPE:DPPC:PI (or PG or PS):CHOL 
114:11:18:1.6. The amount of PI (or DOPG or DOPS) in the
dispersions is tripled in comparison with the amount of PIP2
that was used, to normalize the surface negative charge
density in the dispersions containing PI (or DOPG or
DOPS) to those containing PIP2. The lipid-to-protein molar
ratio for all these bindings is 1700:1. As shown in Fig. 5,
when PIP2 is replaced by PI or DOPG or DOPS (with molar
ratios normalized for charge), the spectra before and after
myr-ARF6 binding are nearly identical. No sharp peak
emerges in the spectra after myr-ARF6 binding.
Bindings of r17-myr-ARF6, r17-non-ARF6, CDC42,
and cytochrome C to the dispersion
Fig. 6 shows ESR spectra from DPPTC in dispersions
before and after binding of r17-myr-ARF6, r17-non-ARF6,
CDC42, and cytochrome C with lipid-to-protein ratios of
1000, 1000, 350, and 1400, respectively. In all cases, the
spectra after binding are essentially identical to that before
binding. This suggests that effects of myr-ARF6 binding on
the structure of lipid bilayers are highly specific and not
mimicked by proteins with similar charge (cytochrome C),
posttranslational modification (r17-myr-ARF6 and r17-non-
ARF6), or even other members of the RAS GTPase super-
family that binds to PIP2 (Zheng et al., 1996). (In addition,
these serve as control experiments that further rule out the
likelihood of artifacts from spin labels not in the membrane
phase when myr-ARF6 is used.)
Binding of myr-ARF6 to LUVs of DOPC/PIP2
(molar ratio of 95;5) and of pure DOPC
The dispersion samples we have used contain a high con-
centration of POPE, which is a non-lamellar phase forming
lipid. We have therefore also studied the binding of myr-
ARF6 to vesicles composed of DOPC/PIP2 (molar ratio of
95:5) and of pure DOPC at a lipid-to-myr-ARF6 molar ratio
500. Here we used LUV samples, because LUVs provide a
better model membrane system compared with actual cells.
The results are shown in Fig. 7, where a small sharper peak
(indicated by an arrow) is seen only in the ESR spectrum
from DPPTC in the LUV containing PIP2, not in the spec-
trum from the LUV of pure DOPC after the same amount of
myr-ARF6 is added to both LUVs. The ESR spectra from
FIGURE 5 ESR spectra from DPPTC in dispersions containing different
negatively charged lipids: PIP2, PI, DOPG, and DOPS before and after
myr-ARF6 binding. The lipid to myr-ARF6 ratio is 1700.
FIGURE 6 ESR spectra from DPPTC in dispersions before and after
binding of r17-myr-ARF6, r17-non-ARF6, CDC42, and cytochrome C.
FIGURE 7 ESR spectra from DPPTC in LUVs of DOPC:PIP2  95:5
and of pure DOPC before and after binding myr-ARF6. The molar ratio of
lipid to myr-ARF6 L/P is 500. The arrow indicates that a sharp peak
emerges after myr-ARF6 binding to the LUV of DOPC:PIP2  95:5.
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LUVs of pure DOPC before and after myr-ARF6 binding
are nearly identical. Clearly, the interaction between myr-
ARF6 and PIP2 is responsible for the sharper peak. Thus,
the presence of a high concentration of PE is not necessary
for the emergence of the sharper peak, but PIP2 is the key
lipid ingredient to interact with myr-ARF6 to induce mem-
brane defects. A matter of practical importance is the extent
to which sharper peaks can be generated. We argue below
that these sharper peaks are associated with defect forma-
tion in the bilayer, but if only a modest number are gener-
ated in a biochemical process, then it may be difficult to
detect them. It would appear that the PE-containing vesicles
enhance or amplify the sharper components to make the
study more convenient.
This is not the first report of sharper components in ESR
spectra from lipid bilayers. Occasionally, sharper compo-
nents in ESR and 31P NMR spectra appear in the literature,
but the interpretation of these changes in spectra has been
controversial. A major objective of this paper is to clarify
the significance of these sharper components and to provide
insights into the effects of ARF6 binding on membranes.
Thus, it would be instructive to include ESR data we ob-
tained from other spin-labeled membrane systems, which
also show sharper components in the spectra as a result of
lipid-lipid and lipid-protein interactions. Let us first con-
sider the simplest membrane system, a pure DPPC disper-
sion.
Sharper peaks in ESR and 31P NMR spectra from
lipid dispersions
ESR spectra of 10PC in DPPC dispersions in the presence
of excess water at temperatures from 20°C to 45°C are
plotted in Fig. 8. Sharper components emerge in the spectra
only between 0°C and 20°C, which are superimposed on
broadened main components. A sharper component in the
spectrum from 8PC (also referred to as 7,6-PC in the liter-
ature (Spink et al., 1990)) in DPPC dispersions, which is
very similar to that shown in Fig. 8, was observed at room
temperature by Spink et al. (1990). They interpreted the
two-component spectrum as evidence for coexistence of gel
and liquid-crystalline phases in DPPC bilayers. If correct,
the sharper peak in the spectra from 10PC in DPPC disper-
sion should persist and grow stronger when the temperature
is raised, until the gel-to-liquid-crystalline phase transition
temperature (Tc), 41°C, is reached. However, the sharper
peak fades away above 30°C, which does not support the
two-phase coexistence explanation. We suggest that the
sharp peaks in ESR spectra from 10PC and 8PC in DPPC
dispersions reflect defects near the C10 position in the
acyl-chain region of the DPPC bilayers. Alternatively, the
10PC spin labels are more effective at seeking out defect
regions, e.g., they are less soluble in the membranes (Earle
et al., 1994). Because defects are typically created by
stresses in bilayers, their existence does not have to be
consistent with a certain phase structure of the bilayer.
A sharp isotropic peak superimposed on a main broad
peak in 31P NMR spectra was observed from DPPC disper-
sions at 50°C (above Tc), from DSPC dispersions at 40°C
(below Tc) (Cullis et al. 1976), and from SM at 40o (near
and below Tc) and 60°C (above Tc) (Cullis and Hope, 1980),
whereas no sharp peak was observed in 31P NMR spectra
from DSPC (Cullis et al., 1976) and SM (Cullis and Hope,
1980) at 20°C (far below Tc). Obviously, there is no corre-
lation between the sharp peak and the phase structure of
lipid bilayers from which the sharp peak was observed. It
was suggested that small unilamellar vesicles could give
rise to sharp peaks in 31P NMR spectra, such as were
observed in the 31P NMR spectra from SM and DPPC
dispersions (Cullis et al. 1976; Cullis and Hope, 1980).
However, these dispersions were prepared in a standard way
without sonication. It is not likely that small unilamellar
vesicles can be produced by such preparations. Therefore,
we suggest that these sharp peaks in the 31P NMR spectra
originate from defects in the headgroup region of bilayers.
Leakage of DPPC vesicles and defects in
the bilayers
It was reported that DPPC vesicles are permeable to a
fluorescence probe carboxyfluorescein (molecular weight
460) (Duzgunes et al., 1983), and our 4PT/VC test agrees
FIGURE 8 Temperature-dependent ESR spectra from 10PC in DPPC
dispersion in the presence of excess water.
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with the report. We found that immediately after addition of
VC (molecular weight 162) to a DPPC dispersion contain-
ing 0.5 mol % 4PT, ESR signals vanished from both the
pellet and supernatant. In contrast, upon addition of VC to
a DOPC dispersion containing 0.5 mol % 4PT, the ESR
signal disappeared from the supernatant but not from the
pellet. Interestingly, the ESR spectrum from 4PT in the
supernatant of DOPC dispersion before addition of VC
differs significantly from that of 4PT in the pellet 1 h after
addition of VC (data not shown). This reveals that the
dynamic structure in the inter-bilayer polar region is distinct
from that in the bulk water phase and that DPPC bilayers
exhibit much more leakage than DOPC bilayers.
These results are curious given that there are at least two
reasons we might expect that DPPC bilayers are less per-
meable than DOPC bilayers. 1) Bilayers are packed more
tightly in the gel phase than in the liquid-crystalline phase.
Usually, bilayers in the gel phase are less permeable than
bilayers in the liquid-crystalline phase (Fettiplace and Hay-
don, 1980). At 23°C, DPPC is in the gel phase, whereas
DOPC is in the liquid-crystalline phase. 2) Introduction of
unsaturated bonds into the acyl chain will increase the
membrane permeability (Bittman and Blau, 1972; Straume
and Litman, 1987). There is a C9-C10 double bond in each
acyl chain of a DOPC molecule.
The contradiction between what we would expect and
what we actually observed might be resolved by the sug-
gestion that a structural defect, possibly a cavity, may exist
in DPPC bilayers. Given that the sharper peak is observed in
the ESR spectra from 8PC and 10PC but not observed in the
spectra from 5PC and 16PC in DPPC dispersions, it is quite
possible that this cavity is located at or near the C8-C10
position in DPPC bilayers, or else these labels more effec-
tively migrate to the defect regions (cf. above). We note that
our findings are consistent with a similar paradigm previ-
ously proposed by Gordeliy et al. (1991) based upon their
neutron scattering observations on DPPC bilayers. We
failed to observe a sharper component in the spectra from
DPPTC in DPPC dispersions between 0°C and 50°C, but
the sharp component appears in 31P NMR spectra from
DPPC. The reason for the discrepancy is possibly as fol-
lows. The population of the sharper component in the spec-
tra from 10PC is less than 5%. Because the main component
in the 10PC spectra is broad, the small sharper component
is easily resolved. But the main component in the DPPTC
spectra is much narrower than that in the 10PC spectra; thus,
it is likely that the sharper component in the DPPTC spectra
cannot be resolved.
Lipid-lipid and lipid-protein interactions can
change amount of defects in bilayers
To explore how defects in bilayers could be affected by
varying lipid composition and interacting with proteins,
Gm1 and CHOL were incorporated sequentially into DPPC
(DSPC) bilayers, and then CTB was added to the lipid
mixture. An ESR spectrum was taken each time after the
composition of the membranes was modified. All these
spectra are plotted together and arranged in two columns in
Fig. 9, A–H. The spectra from 10PC in pure DPPC (pure
DSPC) dispersions is shown in Fig. 9 A (9 E), where the
sharp components are clearly seen in both figures. Addition
of 10 mol % Gm1 to DPPC (DSPC) dispersions increases
the amplitude of the sharp component dramatically, as
shown in Fig. 9 B (9 F). Upon addition of CHOL into the
membrane consisting of DPPC(DSPC)/Gm1  9(9)/1, to
bring it to 50 mol % CHOL, the sharp component almost
disappears, as shown in Fig. 9 C (9 G). However, after
binding of CTB to the membrane (DPPC(DSPC)/Gm1/
CHOL 9(9)/1/10), the sharp component emerges again as
shown in Fig. 9 D (9 H). The implications of these results
are the following. 1) The intensity of sharp components
could be enhanced or depressed simply by varying the
composition of the lipid bilayer; i.e., the amount of defect in
the membrane could be altered by lipid-lipid interactions.
CHOL is especially effective in eliminating defects in the
acyl-chain region of bilayers. This is consistent with the
well known ordering effect of CHOL on the bilayers
(Bloom et al., 1991). That is, CHOL makes the packing of
FIGURE 9 (A and E) ESR spectra from 10PC in pure DPPC and pure
DSPC dispersions, respectively; (B and F) ESR spectra from 10PC in
dispersions with composition DPPC:Gm1  9:1 and DSPC:Gm1  9:1,
respectively; (C and G) ESR spectra from 10PC in dispersions with
composition DPPC:Gm:CHOL  9:1:10 and DSPC:Gm1:CHOL  9:1:
10, respectively; (D and H) ESR spectra from 10PC after CTB binding to
the dispersions with composition DPPC:Gm:CHOL  9:1:10 and DSPC:
Gm1:CHOL  9:1:10, respectively. The sharp peak at the high field wing
of each spectrum is magnified by a factor of 3, so that the change in the
intensity of these sharp peaks with the composition of the membrane can
be seen clearly.
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acyl chain tight and reduces the permeability of bilayers
(Bittman and Blau, 1972; Straume and Litman, 1987; Yan
and Eisenthal, 2000). Interestingly, the sharp component in
the 31P NMR spectrum from pure SM at 60°C disappears
after incorporating equimolar CHOL into SM (Cullis and
Hope, 1980). It reveals that CHOL can also reduce defects
in the headgroup region of bilayers. 2) Lipid-protein inter-
actions can also significantly induce defect formation in
membranes. This has been typified by observations of fu-
sion pores in plasma membranes generated by insertion of
fusion peptide into the membrane in the virus-cell fusion
process. Although there has not yet been any report of an
ESR observation of fusion pores, the sharp component in
the ESR spectrum from a spin-labeled stearic acid incorpo-
rated in DTPG bilayers emerged after addition of melittin
(Kleinschmidt et al., 1997), so this may serve as a good
example for membrane defects induced by lipid-protein
interactions. Because it is known that melittin, a positively
charged peptide, is lytic, fusogenic (Dufourcq et al., 1986),
and capable of inducing a non-lamellar phase (Batenburg et
al., 1987), it is very likely that the sharp component in the
ESR spectrum from spin-labeled stearic acid after melittin
binding to DTPG bilayers arises from defects created in the
DTPG bilayers.
DISCUSSION
Specific interactions between PIP2 and myr-ARF6
and defects in membranes
As shown in Fig. 5 (lower row), among the four spectra of
DPPTC in dispersions containing different negatively
charged lipids after myr-ARF6 binding, the sharp compo-
nent is seen only in the one containing PIP2, not in the
others in which PIP2 is replaced by PI or PG or PS. This
clearly indicates that only in the membrane containing PIP2
can defects be induced in the headgroup region upon GDP-
bound myr-ARF6 binding. In other words, specific interac-
tions between GDP-bound myr-ARF6 and PIP2 do exist that
are responsible for the defect formation in bilayers. Shiffer
et al. (1998) found that PIP2 in RBC membrane can redis-
tribute intracellular cations and lead to loss of phospholipid
asymmetry. Their findings suggest that PIP2 induces pore
formation in RBC membrane. Given that the chemical com-
positions of the RBC membrane differ greatly from the
model membranes we used in this work, which have simple
lipid compositions, it seems that the formation of defects in
all these structures is a function of the presence of PIP2. It
is tempting to speculate that the mechanism for defect
formation in the model membrane and the mechanism for
pore formation in RBC membrane might be similar. More-
over, the specificity in the GDP-bound myr-ARF6/PIP2
interaction is further demonstrated by the inability to gen-
erate such defects in the dispersion containing PIP2 upon
addition of CDC42, which also binds to PIP2 and is an
activator of PLD (Singer et al., 1995).
Mechanisms of ARF6 binding
It has been suggested that two mechanisms are responsible
for myr-ARF binding to biological membranes: 1) the elec-
trostatic interaction between a patch of positively charged
amino residues in ARF and negatively charged headgroups
of acidic lipids in the membrane and 2) the hydrophobic
interaction through insertion of the attached acyl chain on
the amino terminal of ARF into the bilayers. Both interac-
tions acting together bind the protein tightly to the mem-
brane surface (reviewed by McLaughlin and Aderem,
1995). As shown in Fig. 3, ESR spectra from all four spin
labels (DPPTC, 5PC, 10PC, and 16PC) show little or small
changes upon non-ARF6 binding but large changes upon
myr-ARF6 binding. This is consistent with the observation
that myr-ARF5 binds to Golgi membranes, whereas non-
ARF does not (Haun et al., 1993). In addition, Fig. 6 shows
that ESR spectra from DPPTC remain unchanged upon
binding of cytochrome C, a positively charged protein, and
upon binding of r17-myr-ARF6, a myristoylated peptide, to
the dispersion. Taken together, these results suggest that
electrostatic and hydrophobic interactions acting together
can lead to significant alterations in membrane structure
mediated via ARF proteins.
It was found that defects and density fluctuations in
bilayers play a prominent role in modulating phospholipase
A2 activity (Burack et al., 1997). It was proposed that
membrane fusion can be induced by defects in lipid bilayers
(Hui et al., 1981). Our present results suggest that defects in
bilayers are generated by specific interactions between
ARF6 and PIP2, which are both involved in the activation of
PLD (reviewed in Singer et al., 1996; Exton, 1999; Frohman
et al., 1999). The significance of generation of membrane
defects on vesicles by ARF may include 1) providing a
direct access to the substrate in the membrane for phospho-
lipases; 2) increasing the permeability of the membrane to
allow trans-bilayer movement of key components of the
enzyme catalytic process, i.e., dissipation of products and
replenishment of substrates; 3) providing an initial fusion
pore; 4) facilitating the budding vesicle to pinch off; 5)
mediating other lipid-lipid and lipid-protein interactions es-
sential to membrane remodeling. If defects are important for
some membrane proteins to function, then a modification in
lipid composition, which enhances or suppresses defects in
lipid bilayers, may provide an essential mechanism for
regulating these processes (Sen et al., 1991). Interestingly,
the effects of ARF6 in our in vitro system did not require
activation by GTP. The activation of monomeric G proteins
by GTP is a molecular switch in signal transduction pro-
cesses. It is possible that the role of ARF in creating bilayer
defects in intact cells will require activation to initiate
changes in subcellular localization, but such changes are not
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necessary in this in vitro system. Considering the ubiquitous
distribution of ARF proteins and the diversity of biological
functions (e.g., cell signal transduction, endocytosis, exocy-
tosis, and viral entry) with which it has been implicated, the
creation of membrane defects may be of central importance
to these functions.
This study focuses on an important aspect of our main
research goal: the effect of lipid-lipid and lipid-protein
interactions on the dynamic structure of membranes. That
is, we are exploring whether the plasma membrane plays an
active role in various cellular processes. However, the com-
position and structure of plasma membranes are very com-
plicated, for reasons that include the following. 1) Lipid-
lipid, lipid-protein, and protein-protein interactions are
often coupled with one another on the surface of or within
plasma membrane. 2) Both the composition and the struc-
ture of plasma membrane are heterogeneous and dynamic;
e.g., dynamic domain structures in plasma membrane were
found to be involved in cell signal transduction (Field et al.,
1995). Furthermore, it is likely that the amount of defect
induced in a plasma membrane by lipid-lipid and lipid-
protein interactions is small. This raises a question of sen-
sitivity for detection. Thus, one can profit from a model
system, in which the amount of defects is enhanced. This
appears to be the case for the model membrane system used
in our ESR study. It enables us to clearly demonstrate that
only the interaction between PIP2 and myr-ARF6 is respon-
sible for the defect formation in the membrane. The high
concentration of POPE probably enhances the effect of
PIP2/myr-ARF6 interaction on the defect formation, but in
the absence of PIP2 (replaced by PG, PS, or PI), it does not
lead to observable defect formation. In addition, substantial
defects are induced in the LUVs of DOPC that contains
PIP2 upon myr-ARF6 binding. Therefore, PE is not essen-
tial for the defect formation seen by ESR.
We are extending this current study to biological mem-
branes. It is encouraging to note that defects have been
observed in large plasma membrane vesicles derived from
rat basophilic leukemia (RBL) cells upon binding of myr-
ARF6 (M. Ge, A. Costa-Filho, A. Gidwani, D. Holowka, B.
Baird, H.A. Brown, and J.H. Freed, to be published). Thus,
one may expect that myr-ARF6 binding could have a sim-
ilar effect on the plasma membrane of the intact cells.
CONCLUSIONS
Past research has suggested an interaction between myris-
toylated ARF6 and PIP2. This has been demonstrated in the
present study by the formation of sharp components in the
ESR spectrum from the headgroup-labeled DPPC after
binding of myristoylated ARF6 to the vesicle dispersion but
not from dispersions in which PIP2 is replaced by PI, PS, or
PG. This characteristic spectral component is not found in
ESR spectra from DPPTC after addition of CDC42, synthe-
sized peptides of residues 1–17 of myristoylated and non-
myristoylated human ARF6, or cytochrome C. We postulate
that sharp components observed in ESR spectra from spin-
labeled membranes arise from defects in the lipid bilayers,
which are produced as a result of lipid-lipid and lipid-
protein interactions. These findings suggest that ARF may
play a major role in restructuring membranes and in prep-
aration for events that require remodeling of biological
membranes.
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